VitaNova Life Sciences (VNOV) Non-Current Assets (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Non-Current Assets came in at $16038.0 in Q3 2026, little changed on a QoQ basis from $16038.0 in Q2 2026.
Analysis
VitaNova Life Sciences (VNOV) Non-Current Assets (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed Non-Current Assets across 3 years of filings, most recently posting $16038.0 for Q3 2026.
- Non-Current Assets for Q3 2026 came in at $16038.0, changed N/A year-over-year; the trailing twelve-month figure through Jul 2026 was $16038.0 (changed N/A YoY), and the FY2026 annual result was $16038.0, changed N/A from the prior year.
- Non-Current Assets for Q3 2026 stood at $16038.0, roughly flat from $16038.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $16038.0 in Q2 2026 and bottomed at $16038.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 39.87 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 1.89 Bn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 3.97 Bn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 4.57 Bn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 2.81 Bn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 3.24 Bn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 587.72 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 1.95 Bn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 2.18 Bn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | 16,038.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 16,038.00 |
| Jul 31, 2018 | 38,929.00 |
| Apr 30, 2018 | 31,061.00 |
| Jan 31, 2018 | 51,950.00 |
| Oct 31, 2017 | 64,700.00 |
| Apr 30, 2017 | 7,925.00 |